Loading...
OTC Markets
Totals
Securities
12,236
Dollar Vol
$2.5B
Share Vol
3.2B
Trades
318,759

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

ZYXI
Zynex, Inc.

Common Stock

2.53

0.03

1.20%

Delayed (15 Min) Trade Data: 04:00pm 07/24/2025

Zynex, Inc.

9655 Maroon Circle

Englewood, CO 80112

Business Description
Founded in 1996, Zynex is a leading provider of electrotherapy medical devices for pain management and rehabilitation. Zynex is committed to providing the highest-quality patient life through non-invasive rehabilitation products; including NexWave, a electrotherapy device, and the NeuroMove used for recovery of stroke and spinal cord injury patients. Zynex is also developing a non-invasive blood volume monitor for use in hospitals and surgery centers. For additional information, please visit: www.zynex.com
Financial Reporting
Reporting Status
U.S. Reporting: SEC Reporting
Audited Financials
Audited
Latest Report
CIK
0000846475
Fiscal Year End
12/31
Company Officers & Contacts
Thomas Sandgaard
President, CEO

Dan Moorhead
Principal Acct. Officer

Board of Directors
Joshua Robert Disbrow
Audit Committee Member

Joshua R. Disbrow has been employed by us since April 16, 2015. Prior to the closing of the Merger, Mr. Disbrow was the Chief Executive Officer of Luoxis since January 2013. Mr. Disbrow was also the Chief Operating Officer of Ampio since December 2012. Prior to joining Ampio, he served as the Vice President of Commercial Operations at Arbor Pharmaceuticals, a specialty pharmaceutical company, from May 2007 through October 2012. He joined Arbor as that company’s second full-time employee. Mr. Disbrow led the company’s commercial efforts from inception to the company’s acquisition in 2010 and growth to over $127 million in net sales in 2011. By the time Mr. Disbrow departed Arbor in late 2012, he had led the growth of the commercial organization to comprise over 150 people in sales, marketing sales training, managed care, national accounts, and other commercial functions. Mr. Disbrow has spent over 17 years in the pharmaceutical, diagnostic and medical device industries and has held positions of increasing responsibility in sales, marketing, sales management, commercial operations and commercial strategy. Prior to joining Arbor, Mr. Disbrow served as Regional Sales Manager with Cyberonics, Inc., a medical device company focused on neuromodulation therapies from June 2005 through April 2007. Prior to joining Cyberonics he was the Director of Marketing at LipoScience, an in vitro diagnostics company. Mr. Disbrow holds an MBA from Wake Forest University.

Other Company Insiders

Not available

Other Company Insiders are all persons or entities beneficially owning 10% or more of any class of the issuer's securities. Together, officers, directors and other company insiders comprise Company Insiders.
Service Providers
Accounting/Auditing Firm
Plante Moran

8181 East Tufts Avenue

Suite 600

Denver, CO 80237

Investor Relations/Marketing/Communications
Amato and Partners, LLC

90 Park Ave

17th Floor

New York, NY

Securities Counsel
Sichenzia Ross Ference Carmel LLP

1185 Avenue of the Americas,

31st Floor

New York, NY 10036

Profile Data
SIC - Industry Classification
3845 - Electromedical equipment
Incorporation Information
NV, US, 1996
Employees
160 as of 01/29/2019
Shell
No
Products and Services

Not available

Company Facilities

Not available

Company Notes
Formerly=Zynex Medical Holdings, Inc. until 7-2008
Formerly=Fox River Holdings, Inc. until 1-04
Formerly=Arizona Ventures, Inc. until 10-03
Formerly=China Global Development, Inc. (New) until 11-02
Formerly=iBonZai.com, Inc. until 1-02
Formerly=Life Medical Technologies, Inc. until 5-00
Formerly=I-Sim International Corp. until 1-00
Formerly=Life Medical Technologies, Inc. until 7-99
Formerly=Media USA, Inc. until 3-94
Nasdaq
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.